The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdinburgh Investment Trust PLC Regulatory News (EDIN)

Share Price Information for Edinburgh Investment Trust PLC (EDIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 722.00
Bid: 720.00
Ask: 722.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.278%)
Open: 725.00
High: 727.00
Low: 720.00
Prev. Close: 722.00
EDIN Live PriceLast checked at -
Edinburgh Investment is an Investment Trust

To achieve an increase of the NAV per share in excess of the growth in the FTSE All-Share Index and dividend growth that exceeds UK inflation rate by investing primarily in UK securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of AIFM & Portfolio Update

1 Apr 2022 08:19

RNS Number : 9260G
Edinburgh Investment Trust PLC
01 April 2022
 

THE EDINBURGH INVESTMENT TRUST PLC

 

LEI: 549300HV0VXCRONER808

 

1 April 2022

 

Change of Alternative Investment Fund Manager ("AIFM") & Portfolio Update

The Directors of Edinburgh Investment Trust (the "Company") announce that the Company's AIFM changes today from Majedie Asset Management Limited ("Majedie") to Liontrust Fund Partners LLP following the completion of the acquisition of Majedie by Liontrust Asset Management PLC ("Liontrust"). In addition, the Company provides a portfolio update from the portfolio manager.

The Company today also launches a new website at edinburghinvestmenttrust.com and which is additionally available at Liontrust's new website. The website contains key regulatory documents, performance, holdings, regular updates and announcements, along with other information about the Company. Shareholders and other interested parties may also register through the website to receive notifications on a range of Company announcements.

AIFM

Liontrust announced on 7 December 2021 that it would acquire Majedie. This acquisition has now completed and today Liontrust Fund Partners LLP becomes the Company's AIFM, with Liontrust Investment Partners LLP the investment manager. The Company's portfolio management team, with James de Uphaugh as the portfolio manager and Chris Field as the deputy manager, remains unchanged. James and Chris, along with the rest of the Majedie investment team and other colleagues, are now part of the Liontrust Group. The investment team will continue to be led by James and will operate as the Liontrust Global Fundamental team. The team's investment process, including the integration of ESG factors, remains the same.

James de Uphaugh, portfolio manager of the Company, said:

"This is the beginning of an exciting new chapter for me and my investment colleagues in Liontrust's Global Fundamental team. The primary qualities that Majedie has embodied since our earliest days - a laser focus on performance, a commitment to responsible capitalism, the highest levels of client service, and alignment of interests with our clients through equity ownership and co-investment - will endure as we join Liontrust. The cultural fit of our two organisations is nicely matched and we are looking forward to the opportunity to focus on generating further attractive long-term returns for Edinburgh Investment Trust's shareholders.

"Markets have seen increased volatility this year and there has been a shift in the characteristics of stocks that the market has rewarded. In this environment we have found some compelling new opportunities to complement the portfolio's existing holdings."

Glen Suarez, Chairman of the Company, commented:

"Since we appointed Majedie as the manager of Edinburgh we have been encouraged by the rigour of the investment process and the evolving track record. The transition of our investment management team to Liontrust will not result in any changes to the proven investment process, and the Company stands to benefit from Liontrust's wealth of experience in the promotion of savings vehicles to retail investors."

Portfolio Update

In the two years since James and the investment team were appointed, both the NAV and share price (31 March 2020 to 30 March 2022 - the most recent date available) have outperformed the FTSE All Share Index by 4.5% per annum and 7.8% per annum respectively. The positioning of the portfolio for a post-pandemic economic recovery has been an important factor, with notable positive contributors to the investment track record coming from holdings including Anglo American, Ashtead, NatWest, Weir and Wm Morrison.

Edinburgh Investment Trust, total returns, Sterling, from 31 March 2020 to 30 March 2022

 

Cumulative, %

Per annum, %

Outperformance per annum, %

Net Asset Value

55.3

24.7

+4.5

Share price

63.4

27.9

+7.8

FTSE All-Share index

44.3

20.2

 

Source: Liontrust Fund Partners LLP. Net Asset Value is shown with debt at market value.

The portfolio's current positioning remains well diversified. This remains an important feature of the investment approach, particularly given the prevailing uncertainties arising from the war in Ukraine, rising inflation and the energy crisis. At present, there is a bias towards stocks in sectors such as Food Retail, Defence and Mining: some of the portfolio's biggest positions include Tesco, BAE Systems and Newmont. Despite the current geopolitical uncertainty, the UK market continues to offer a rich seam of opportunities for investors in the portfolio manager's view. These should drive attractive long-term returns through a combination of operational progress and attractive starting valuations. Material recent purchases include GlaxoSmithKline, Unilever, Centrica and Marks & Spencer.

At 30 March 2022, the Company's net gearing (borrowings less cash and cash equivalents, with debt at market value) was 4.3% of net assets, supporting the manager's contention that the portfolio should deliver attractive long-term returns to shareholders.

The Company expects to announce full year results, to 31 March 2022, on 26 May 2022.

 

Enquiries

Edinburgh Investment Trust plc

Glen Suarez (Chairman) via Montfort below

Liontrust Fund Partners LLP

James Mowat +44 20 3908 8822

Investec Bank plc

Tom Skinner +44 20 7579 4000

Sanne Fund Services (UK) Limited (Company Secretary)

David Rice +44 20 3327 9720

Montfort Communications

Gay Collins +44 7798 626282

Shireen Farhana +44 7757 299250

Ella Henderson +44 7762 245122

eit@montfort.london

Notes

The Company's twin objectives are (1) an increase of the Net Asset Value per share in excess of the growth of the FTSE All-Share index and (2) growth in dividends per share in excess of the rate of inflation. To achieve this, the portfolio manager constructs a high-conviction, differentiated and diversified portfolio of listed equities. The investment approach is flexible and 'total return', i.e. shareholder returns should come through a combination of income and capital growth over the long term. Stocks that might be labelled 'growth', 'value' and 'recovery' may all be held. At least 80% of assets are invested in UK-listed shares.

Top ten holdings, as a percentage of total assets, at 30 March 2022

Shell 6.8%

Tesco 5.0%

Anglo American 4.7%

AstraZeneca 4.2%

BAE Systems 4.2%

Unilever 4.1%

NatWest 3.5%

Ashtead 3.4%

Weir 2.9%

Electrocomponents 2.8%

Source: Liontrust Fund Partners LLP.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSISWFEESEFL
Date   Source Headline
30th Apr 202411:15 amRNSNet Asset Value(s)
29th Apr 202411:29 amRNSNet Asset Value(s)
26th Apr 202411:31 amRNSNet Asset Value(s)
25th Apr 202411:09 amRNSNet Asset Value(s)
24th Apr 202411:40 amRNSNet Asset Value(s)
24th Apr 20247:00 amRNSDividend Declaration
23rd Apr 202411:03 amRNSNet Asset Value(s)
22nd Apr 20245:16 pmRNSTransaction in Own Shares
22nd Apr 202410:55 amRNSNet Asset Value(s)
19th Apr 202411:06 amRNSNet Asset Value(s)
18th Apr 202411:06 amRNSNet Asset Value(s)
18th Apr 20248:45 amRNSCompliance with Market Abuse Regulation
17th Apr 202410:56 amRNSNet Asset Value(s)
16th Apr 202410:42 amRNSNet Asset Value(s)
15th Apr 20245:09 pmRNSTransaction in Own Shares
15th Apr 20245:05 pmRNSDirector/PDMR Shareholding
15th Apr 202411:04 amRNSNet Asset Value(s)
15th Apr 20249:22 amRNSDirector Declaration
12th Apr 202410:54 amRNSNet Asset Value(s)
11th Apr 20245:12 pmRNSTransaction in Own Shares
11th Apr 202411:18 amRNSNet Asset Value(s)
10th Apr 20245:39 pmRNSTransaction in Own Shares
10th Apr 202410:41 amRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 202411:17 amRNSNet Asset Value(s)
8th Apr 20245:29 pmRNSTransaction in Own Shares
8th Apr 202410:18 amRNSNet Asset Value(s)
5th Apr 202410:58 amRNSNet Asset Value(s)
4th Apr 202411:24 amRNSNet Asset Value(s)
3rd Apr 20245:40 pmRNSTransaction in Own Shares
3rd Apr 202411:38 amRNSNet Asset Value(s)
2nd Apr 20245:29 pmRNSTransaction in Own Shares
2nd Apr 202411:31 amRNSNet Asset Value(s)
2nd Apr 202411:09 amRNSTotal Voting Rights
28th Mar 20245:28 pmRNSTransaction in Own Shares
28th Mar 202411:41 amRNSNet Asset Value(s)
27th Mar 20245:15 pmRNSTransaction in Own Shares
27th Mar 202411:09 amRNSNet Asset Value(s)
26th Mar 20245:31 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSDirector/PDMR Shareholding
26th Mar 202410:27 amRNSNet Asset Value(s)
25th Mar 20245:03 pmRNSTransaction in Own Shares
25th Mar 202410:45 amRNSNet Asset Value(s)
22nd Mar 20245:21 pmRNSTransaction in Own Shares
22nd Mar 202411:09 amRNSNet Asset Value(s)
21st Mar 20245:26 pmRNSTransaction in Own Shares
21st Mar 202410:47 amRNSNet Asset Value(s)
20th Mar 20245:53 pmRNSTransaction in Own Shares
20th Mar 202410:37 amRNSNet Asset Value(s)
19th Mar 20245:19 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.